Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

FNCH

Finch Therapeutics (FNCH)

Finch Therapeutics Group Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:FNCH
日付受信時刻ニュースソース見出しコード企業名
2024/05/1805 : 45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FNCHFinch Therapeutics Group Inc
2024/05/1105 : 45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FNCHFinch Therapeutics Group Inc
2024/02/2406 : 12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FNCHFinch Therapeutics Group Inc
2023/12/1407 : 20Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:FNCHFinch Therapeutics Group Inc
2023/11/1806 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FNCHFinch Therapeutics Group Inc
2023/11/0820 : 30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FNCHFinch Therapeutics Group Inc
2023/08/1119 : 31Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:FNCHFinch Therapeutics Group Inc
2023/08/1019 : 31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FNCHFinch Therapeutics Group Inc
2023/07/0805 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FNCHFinch Therapeutics Group Inc
2023/06/2905 : 31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FNCHFinch Therapeutics Group Inc
2023/06/2905 : 31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FNCHFinch Therapeutics Group Inc
2023/06/2405 : 31Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:FNCHFinch Therapeutics Group Inc
2023/06/1006 : 01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FNCHFinch Therapeutics Group Inc
2023/06/1005 : 53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FNCHFinch Therapeutics Group Inc
2023/06/1005 : 23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FNCHFinch Therapeutics Group Inc
2023/06/1005 : 17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FNCHFinch Therapeutics Group Inc
2023/06/1005 : 16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FNCHFinch Therapeutics Group Inc
2023/06/1005 : 16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FNCHFinch Therapeutics Group Inc
2023/06/0920 : 00GlobeNewswire Inc.Finch Announces Reverse Stock Split of Common StockNASDAQ:FNCHFinch Therapeutics Group Inc
2023/05/3105 : 07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FNCHFinch Therapeutics Group Inc
2023/05/1905 : 15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FNCHFinch Therapeutics Group Inc
2023/05/1705 : 17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FNCHFinch Therapeutics Group Inc
2023/05/1205 : 13Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FNCHFinch Therapeutics Group Inc
2023/05/1205 : 05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FNCHFinch Therapeutics Group Inc
2023/05/1020 : 15Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FNCHFinch Therapeutics Group Inc
2023/05/1020 : 13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FNCHFinch Therapeutics Group Inc
2023/05/1020 : 00GlobeNewswire Inc.Finch Therapeutics Reports First Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:FNCHFinch Therapeutics Group Inc
2023/04/2705 : 05Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:FNCHFinch Therapeutics Group Inc
2023/04/2705 : 03Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FNCHFinch Therapeutics Group Inc
2023/04/2705 : 02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:FNCHFinch Therapeutics Group Inc
 Showing the most relevant articles for your search:NASDAQ:FNCH

最近閲覧した銘柄

Delayed Upgrade Clock